Merdury Biopharmaceutical Corp
TPEX:6932
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merdury Biopharmaceutical Corp
TPEX:6932
|
TW |
|
Marka Yatirim Holding AS
IST:MARKA.E
|
TR |
|
Bite Acquisition Corp
NASDAQ:ABVE
|
US |
|
R
|
Recticel NV
SWB:RCZ
|
BE |
|
I
|
Ideal Group of Companies Inc
OTC:IDGR
|
US |
|
M
|
Mekong Fisheries JSC
VN:AAM
|
VN |
|
I
|
Inland Printers Ltd
BSE:530787
|
IN |
|
Shoei Yakuhin Co Ltd
TSE:3537
|
JP |
|
Forsys Metals Corp
TSX:ARN
|
CA |
|
N
|
Nuvve Holding Corp
NASDAQ:NVVE
|
US |
|
N
|
Nokwon Commercials & Industries Inc
KOSDAQ:065560
|
KR |
|
R
|
Roof Renovation SA
WSE:RRH
|
PL |
Bankruptcy Probability
Merdury Biopharmaceutical Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Merdury Biopharmaceutical Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TW |
M
|
Merdury Biopharmaceutical Corp
TPEX:6932
|
2.3B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
654.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
372.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
240.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
187.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
272.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Merdury Biopharmaceutical Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Merdury Biopharmaceutical Corp has total debt of 42m TWD. This includes both short-term (0 TWD) and long-term (42m TWD) debt.
You can find a full breakdown on its Balance Sheet.
